The closing price of Vaxart Inc (NASDAQ: VXRT) was $1.22 for the day, down -0.81% from the previous closing price of $1.23. In other words, the price has decreased by -$0.0100 from its previous closing price. On the day, 799939 shares were traded.
Ratios:
Our analysis of VXRT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.32 and its Current Ratio is at 3.32. In the meantime, Its Debt-to-Equity ratio is 0.46 whereas as Long-Term Debt/Eq ratio is at 0.35.
On November 02, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $15.
B. Riley Securities Downgraded its Buy to Neutral on June 29, 2021, whereas the target price for the stock was revised from $13 to $9.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VXRT now has a Market Capitalization of 212.11M and an Enterprise Value of 192.49M. For the stock, the TTM Price-to-Sale (P/S) ratio is 28.74 while its Price-to-Book (P/B) ratio in mrq is 3.24. Its current Enterprise Value per Revenue stands at 26.09 whereas that against EBITDA is -2.67.
Stock Price History:
Over the past 52 weeks, VXRT has reached a high of $1.59, while it has fallen to a 52-week low of $0.53. The 50-Day Moving Average of the stock is 1.1216, while the 200-Day Moving Average is calculated to be 0.8277.
Shares Statistics:
VXRT traded an average of 2.01M shares per day over the past three months and 1.6M shares per day over the past ten days. A total of 173.86M shares are outstanding, with a floating share count of 171.49M. Insiders hold about 1.36% of the company’s shares, while institutions hold 18.03% stake in the company. Shares short for VXRT as of Feb 29, 2024 were 13.71M with a Short Ratio of 6.83, compared to 11.11M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.94% and a Short% of Float of 8.99%.
Earnings Estimates
The firm’s stock currently is rated by 3 analysts. On average, analysts expect EPS of -$0.14 for the current quarter, with a high estimate of -$0.1 and a low estimate of -$0.18, while EPS last year was -$0.19. The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.12 and low estimates of -$0.15.
Analysts are recommending an EPS of between -$0.32 and -$0.62 for the fiscal current year, implying an average EPS of -$0.45. EPS for the following year is -$0.39, with 3 analysts recommending between -$0.19 and -$0.56.
